Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that it has opened
enrollment for a Phase Ib clinical trial
Corning Life Sciences announced last month that it has entered into a collaboration with TAP Biosystems to provide a manufacturing
automation solution for large-scale, attachment-dependent cell culture
As demand for stem cells for both drug discovery and clinical applications grows, effectively translating the promise of stem cells into
therapeutic reality will require large-scale “industrialized” production under tightly controlled conditions.
news isn’t inherently bad just because it’s not what we expected or wanted, and it should be allowed to inform our subsequent decisions just as much as the
good news. We’re just going to have to learn to discuss it like adults.